Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)

  1. Drake, M.J.
  2. MacDiarmid, S.
  3. Chapple, C.R.
  4. Esen, A.
  5. Athanasiou, S.
  6. Cambronero Santos, J.
  7. Mitcheson, D.
  8. Herschorn, S.
  9. Siddiqui, E.
  10. Huang, M.
  11. Stoelzel, M.
Revue:
International Journal of Clinical Practice

ISSN: 1742-1241,  1368-5031

Année de publication: 2017

Volumen: 71

Número: 5

Type: Article

DOI: 10.1111/IJCP.12944 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus